PRNewswire (Thu, 29-Jan 12:53 PM ET)
cbdMD Announces Strategic Acquisition of Bluebird Botanicals
PRNewswire (Wed, 14-Jan 9:01 AM ET)
PRNewswire (Fri, 19-Dec 4:10 PM ET)
cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement
PRNewswire (Fri, 19-Dec 3:01 PM ET)
AB Digital Inc (Thu, 18-Dec 4:05 PM ET)
PRNewswire (Wed, 17-Dec 7:17 PM ET)
cbdMD, Inc. Regains Compliance with NYSE American Listing Standards
PRNewswire (Mon, 8-Dec 11:09 AM ET)
cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results
PRNewswire (Fri, 21-Nov 8:30 AM ET)
YCBD Raises $1.7 Million Through Series B Preferred Placement—Key Growth and Balance Sheet Takeaways
Market Chameleon (Thu, 2-Oct 7:17 AM ET)
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Cbdmd trades on the AMEX stock market under the symbol YCBD.
As of January 30, 2026, YCBD stock price climbed to $1.07 with 24,154,475 million shares trading.
YCBD has a beta of 1.38, meaning it tends to be more sensitive to market movements. YCBD has a correlation of 0.03 to the broad based SPY ETF.
YCBD has a market cap of $11.23 million. This is considered a Sub-Micro Cap stock.
Last quarter Cbdmd reported $5 million in Revenue and -$.08 earnings per share. This beat revenue expectation by $18,980 and missed earnings estimates by -$.01.
In the last 3 years, YCBD traded as high as $136.44 and as low as $.47.
The top ETF exchange traded funds that YCBD belongs to (by Net Assets): VXF.
YCBD has underperformed the market in the last year with a return of -75.7%, while SPY returned +15.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in YCBD shares. However, YCBD has outperformed the market in the last 3 month and 2 week periods, returning +12.6% and +5.9%, while SPY returned +0.7% and -0.3%, respectively. This indicates YCBD has been having a stronger performance recently.
YCBD support price is $.71 and resistance is $.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that YCBD shares will trade within this expected range on the day.
